Plain-English translation of NCT07115940 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
SELECT LATE is testing whether patients who have a stroke caused by a blood clot in a major brain artery—but arrive for treatment more than 24 hours after the stroke began—benefit from a procedure called endovascular thrombectomy in addition to standard medical care. This procedure uses a catheter (thin tube) to physically remove the clot and restore blood flow to the brain. The trial will compare outcomes in patients who receive this procedure plus medications versus those who receive medications alone.
Most stroke clot-removal procedures are only done within the first 24 hours, because doctors aren't sure if the procedure helps patients who arrive later. This trial exists to find out whether removing the clot between 24 and 72 hours after stroke onset can still improve recovery and quality of life.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to one of two groups: one group will receive the clot removal procedure plus standard stroke medications, and the other will receive standard medications alone. You will have assessments at enrollment, 24 hours later, at hospital discharge, and then at 90 days and 1 year after your stroke. These visits will include neurological exams, imaging scans, and questionnaires about your recovery and quality of life.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States